Carl W. Hull's most recent trade in Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A was a trade of 175,000 Class A Common Stock done at an average price of $5.6 . Disclosure was reported to the exchange on Nov. 11, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Maravai LifeSciences Holdings Inc (Class A) | Carl W. Hull | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 5.64 per share. | 11 Nov 2024 | 175,000 | 175,000 | - | 5.6 | 987,000 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Carl W. Hull | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.70 per share. | 15 Mar 2024 | 17,560 | 267,072 | - | 7.7 | 135,212 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Hull W. Carl | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.48 per share. | 15 Feb 2024 | 10,729 | 284,632 | - | 5.5 | 58,795 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Carl W. Hull | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 75,842 | 295,361 | - | - | Class A Common Stock | |
| Maravai LifeSciences Holdings Inc (Class A) | Carl W. Hull | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 270,109 | 270,109 | - | - | Employee Stock Options (Right to Buy) | |
| Maravai LifeSciences Holdings Inc (Class A) | Carl W. Hull | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 147,638 | 219,519 | - | - | Class A Common Stock | |
| Maravai LifeSciences Holdings Inc (Class A) | Carl W. Hull | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.23 per share. | 15 Feb 2023 | 9,719 | 71,881 | - | 15.2 | 148,020 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Carl W. Hull | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 151,200 | 151,200 | - | - | Employee Stock Options (Right to Buy) | |
| Maravai LifeSciences Holdings Inc (Class A) | Carl W. Hull | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 81,600 | 81,600 | - | - | Class A Common Stock |